Assenagon Asset Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.07M Buy
2025
Q2
$1.35M Buy
2025
Q1
$662K Hold
2024
Q4
$1.03M Sell
2024
Q3
$13M Buy
2024
Q2
$1.12M Buy